+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2023-2030

  • PDF Icon

    Report

  • 184 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5470856
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Clinical Trial Supply & Logistics Market size was estimated at USD 22.59 billion in 2022, USD 24.33 billion in 2023, and is expected to grow at a CAGR of 7.74% to reach USD 41.04 billion by 2030.

Clinical trial supply & logistics encompasses the planning, management, storage, and distribution of clinical trial materials (CTMs) needed to conduct clinical studies. These materials include investigational medicinal products (IMPs), placebos, patient kits, ancillary supplies, and labeling services. The main objective of CTSL is to ensure that clinical trials are conducted efficiently and in compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines while maintaining product quality and integrity. The prevalence of chronic disorders and increasing government investments in pharmaceutical research & development process drives the use of clinical trial supply & logistics. On the contrary, the cost-intensive nature of clinical trials and the limited availability of trained professionals hinders market growth. However, growing interest in drug development projects coupled with outsourcing clinical trials is expected to increase its usage in the coming years.

Regional Insights

In the Americas region, North America has considerable utilization of clinical trial supply & logistics, with the United States leading the growth with its robust pharmaceutical industry and extensive investment in research and development (R&D). Furthermore, numerous leading pharmaceutical companies conducting clinical trials and strong government support for R&D activities drive market expansion. South America also contributes to increasing clinical trial supply & logistics usage due to its developing healthcare infrastructure and growing focus on clinical research. The Asia-Pacific region’s clinical trial supply & logistics market is growing rapidly due to its rapidly evolving pharmaceutical industry in China, India, South Korea, Taiwan, Indonesia, and Vietnam, among others. Moreover, many multinational pharmaceutical companies have established their R&D centers or collaborations with local partners in this region due to resource availability at competitive prices. Within the EMEA region, Europe has been traditionally considered a stronghold for the global clinical trial supply & logistics market due to the presence of numerous pharmaceutical and biotechnology companies. The European Union (EU) has a well-established framework for conducting clinical trials across its member states that ensures the safety, efficacy, and quality of investigational medicinal products (IMPs). In addition, Middle East & Africa are emerging markets within the EMEA region due to increasing healthcare expenditure by governments, expansion of multinational pharmaceutical companies into these markets to tap a larger patient pool for testing their investigational drugs/devices, continuous development of healthcare infrastructure and availability of skilled workforce due to their investments in education.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supply & Logistics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supply & Logistics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Almac Group, Ancillare, LP, Beroe Holdings Inc., Biocair International Limited, Catalent, Inc., Clinigen Group PLC, COREX LOGISTICS LIMITED, Deutsche Post AG, Eurofins Scientific Group, ICON PLC, Inceptua S.A., Infosys Limited, KLIFO A/S, Liveo Research GmbH, Lonza Group AG, Marken Limited, Myonex, Inc., N-SIDE SA, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Solutions, SAP SE, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific, Inc., and Walden Group.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Comparator Sourcing
    • Logistics & Distribution
      • Cold Chain Distribution
      • Non-Cold Chain Distribution
    • Manufacturing
    • Packaging, Labeling, & Blinding
    • Storage & Retention
  • Type
    • Biologic Drugs
    • Medical Devices
    • Small Molecules
  • Phase
    • BA/ BE studies
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • Therapeutic Area
    • Blood Disorders
    • Cardiovascular Diseases
    • CNS & Mental Disorders
    • Dermatological Disorders
    • Digestive Disorders
    • ENT Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Nephrology
    • Oncology
    • Rare Diseases
    • Respiratory Disorders
  • End User
    • Contract Research Organisations (CROs)
    • Medical Devices Companies
    • Pharmaceutical & Biotechnology companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Clinical Trial Supply & Logistics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supply & Logistics Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Trial Supply & Logistics Market?
  4. What is the market share of the leading vendors in the Clinical Trial Supply & Logistics Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Trial Supply & Logistics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Trial Supply & Logistics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence of Chronic Diseases Globally
5.1.1.2. Rising Government Funds to R&D Activities
5.1.1.3. Globalization of Clinical Trials and Harmonization of Regulations
5.1.2. Restraints
5.1.2.1. High Cost Associated With the Clinical Trials
5.1.3. Opportunities
5.1.3.1. Rising Focus on Drug Development with the Launch of New Drugs
5.1.3.2. Outsourcing of Clinical Trial Activity
5.1.4. Challenges
5.1.4.1. Lack of Skilled Person to Operate Devices During Clinical Trials
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Clinical Trial Supply & Logistics Market, by Services
6.1. Introduction
6.2. Comparator Sourcing
6.3. Logistics & Distribution
6.4.1. Cold Chain Distribution
6.4.2. Non-Cold Chain Distribution
6.4. Manufacturing
6.5. Packaging, Labeling, & Blinding
6.6. Storage & Retention
7. Clinical Trial Supply & Logistics Market, by Type
7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small Molecules
8. Clinical Trial Supply & Logistics Market, by Phase
8.1. Introduction
8.2. BA/ BE studies
8.3. Phase 1
8.4. Phase 2
8.5. Phase 3
8.6. Phase 4
9. Clinical Trial Supply & Logistics Market, by Therapeutic Area
9.1. Introduction
9.2. Blood Disorders
9.3. Cardiovascular Diseases
9.4. CNS & Mental Disorders
9.5. Dermatological Disorders
9.6. Digestive Disorders
9.7. ENT Diseases
9.8. Immunology
9.9. Infectious Diseases
9.10. Metabolic Disorders
9.11. Nephrology
9.12. Oncology
9.13. Rare Diseases
9.14. Respiratory Disorders
10. Clinical Trial Supply & Logistics Market, by End User
10.1. Introduction
10.2. Contract Research Organisations (CROs)
10.3. Medical Devices Companies
10.4. Pharmaceutical & Biotechnology companies
11. Americas Clinical Trial Supply & Logistics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Trial Supply & Logistics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Agreement, Collaboration, & Partnership
14.3.1.1. Vial Announces Strategic Partnership with Royale International Group
14.3.2. Award, Recognition, & Expansion
14.3.2.1. Catalent Starts Construction of USD 20M Expansion at Clinical Supply Facility in Germany
14.3.2.2. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Almac Group
15.1.2. Ancillare, LP
15.1.3. Beroe Holdings Inc.
15.1.4. Biocair International Limited
15.1.5. Catalent, Inc.
15.1.6. Clinigen Group PLC
15.1.7. COREX LOGISTICS LIMITED
15.1.8. Deutsche Post AG
15.1.9. Eurofins Scientific Group
15.1.10. ICON PLC
15.1.11. Inceptua S.A.
15.1.12. Infosys Limited
15.1.13. KLIFO A/S
15.1.14. Liveo Research GmbH
15.1.15. Lonza Group AG
15.1.16. Marken Limited
15.1.17. Myonex, Inc.
15.1.18. N-SIDE SA
15.1.19. Octalsoft
15.1.20. Parexel International Corporation
15.1.21. PCI Pharma Services
15.1.22. PHOENIX Pharmahandel GmbH & Co KG
15.1.23. Piramal Pharma Solutions
15.1.24. SAP SE
15.1.25. Signant Health
15.1.26. SIRO Clinpharm Private Limited
15.1.27. Thermo Fisher Scientific, Inc.
15.1.28. Walden Group
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
FIGURE 7. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
FIGURE 8. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2022 VS 2030 (%)
FIGURE 12. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
FIGURE 14. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 16. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 26. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • Almac Group
  • Ancillare, LP
  • Beroe Holdings Inc.
  • Biocair International Limited
  • Catalent, Inc.
  • Clinigen Group PLC
  • COREX LOGISTICS LIMITED
  • Deutsche Post AG
  • Eurofins Scientific Group
  • ICON PLC
  • Inceptua S.A.
  • Infosys Limited
  • KLIFO A/S
  • Liveo Research GmbH
  • Lonza Group AG
  • Marken Limited
  • Myonex, Inc.
  • N-SIDE SA
  • Octalsoft
  • Parexel International Corporation
  • PCI Pharma Services
  • PHOENIX Pharmahandel GmbH & Co KG
  • Piramal Pharma Solutions
  • SAP SE
  • Signant Health
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific, Inc.
  • Walden Group

Methodology

Loading
LOADING...

Table Information